Boston Scientific (BSX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $44.14, +2.65% vs the prior close of $43.00.
- Volume 15.86M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BSX rises 2.7% to $44.14. Closed at $44.14, +2.65% vs the prior close of $43.00. Day range $43.46–$44.43, opened at $43.95.
BSX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — BSX rises 2.7% to $44.14
- Closed at $44.14, +2.65% vs the prior close of $43.00. Day range $43.46–$44.43, opened at $43.95.
- Volume was 15.86M shares, 0.8x its 50-day average of 19.25M.
- Price is -4.4% vs its 50-day average ($46.18) and -25.6% vs its 200-day average ($59.36).
- 52-week range $41.39–$105.65; today's close sits at 4% of that range, 58.2% below the 52-week high.
Oct 14, 2026 — BSX dips 0.7% to $43.00
- Closed at $43.00, -0.72% vs the prior close of $43.31. Day range $42.28–$43.58, opened at $43.40.
- Volume was 15.10M shares, 0.8x its 50-day average of 19.38M.
- Price is -7.0% vs its 50-day average ($46.26) and -27.9% vs its 200-day average ($59.62).
- 52-week range $41.39–$105.65; today's close sits at 3% of that range, 59.3% below the 52-week high.
Oct 13, 2026 — BSX dips 1.2% to $43.31
- Closed at $43.31, -1.21% vs the prior close of $43.84. Day range $42.46–$44.15, opened at $43.95.
- Volume was 14.27M shares, 0.7x its 50-day average of 19.50M.
- Price is -6.6% vs its 50-day average ($46.38) and -27.7% vs its 200-day average ($59.88).
- 52-week range $41.39–$105.65; today's close sits at 3% of that range, 59.0% below the 52-week high.
Oct 12, 2026 — BSX rises 2.6% to $43.84, 3 up days in a row
- Closed at $43.84, +2.60% vs the prior close of $42.73. Day range $42.67–$43.92, opened at $43.10.
- Volume was 13.60M shares, 0.7x its 50-day average of 19.60M.
- Price is -5.7% vs its 50-day average ($46.48) and -27.1% vs its 200-day average ($60.15).
- 52-week range $41.39–$105.65; today's close sits at 4% of that range, 58.5% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — BSX rises 1.6% to $42.73
- Closed at $42.73, +1.64% vs the prior close of $42.04. Day range $41.97–$42.83, opened at $42.12.
- Volume was 13.04M shares, 0.7x its 50-day average of 19.86M.
- Price is -8.2% vs its 50-day average ($46.54) and -29.3% vs its 200-day average ($60.41).
- 52-week range $41.39–$105.65; today's close sits at 2% of that range, 59.6% below the 52-week high.
Oct 8, 2026 — BSX rises 1.1% to $42.04
- Closed at $42.04, +1.11% vs the prior close of $41.58. Day range $41.39–$42.27, opened at $41.50.
- Volume was 22.87M shares, 1.1x its 50-day average of 20.43M.
- Price is -9.8% vs its 50-day average ($46.60) and -30.7% vs its 200-day average ($60.68).
- 52-week range $41.39–$105.65; today's close sits at 1% of that range, 60.2% below the 52-week high.
Oct 7, 2026 — BSX dips 1.4% to $41.58, a 52-week low, 7 down days in a row
- Closed at $41.58, -1.45% vs the prior close of $42.19. Day range $41.50–$42.52, opened at $42.19.
- Volume was 15.89M shares, 0.8x its 50-day average of 20.65M.
- Price is -10.9% vs its 50-day average ($46.68) and -31.8% vs its 200-day average ($60.95).
- 52-week range $41.50–$105.65; today's close sits at 0% of that range, 60.6% below the 52-week high.
- That makes 7 straight losses.
- SEC filings that day: 8-K.
Oct 6, 2026 — BSX dips 0.5% to $42.19, a 52-week low, 6 down days in a row
- Closed at $42.19, -0.50% vs the prior close of $42.40. Day range $42.00–$42.75, opened at $42.47.
- Volume was 12.55M shares, 0.6x its 50-day average of 20.80M.
- Price is -9.8% vs its 50-day average ($46.77) and -31.1% vs its 200-day average ($61.22).
- 52-week range $41.94–$105.65; today's close sits at 0% of that range, 60.1% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — BSX dips 0.5% to $42.40, a 52-week low, 5 down days in a row
- Closed at $42.40, -0.47% vs the prior close of $42.60. Day range $42.29–$43.30, opened at $42.53.
- Volume was 13.74M shares, 0.7x its 50-day average of 20.94M.
- Price is -9.5% vs its 50-day average ($46.84) and -31.0% vs its 200-day average ($61.48).
- 52-week range $41.94–$105.65; today's close sits at 1% of that range, 59.9% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — BSX dips 1.5% to $42.60, a 52-week low, 4 down days in a row
- Closed at $42.60, -1.46% vs the prior close of $43.23. Day range $41.94–$43.44, opened at $43.32.
- Volume was 18.31M shares, 0.9x its 50-day average of 20.90M.
- Price is -9.1% vs its 50-day average ($46.88) and -31.0% vs its 200-day average ($61.73).
- 52-week range $41.94–$105.65; today's close sits at 1% of that range, 59.7% below the 52-week high.
- That makes 4 straight losses.
BSX latest news & SEC filings
Every SEC filing by or about BSX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 8.01 — Reported other events the company considers important.
Sep 23, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 8, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.05 — Material cybersecurity incident.
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 26, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Morano Susan E bought 2,040 shares at $49.22 (≈$100.41K) on Aug 25, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 26, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 12, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 11, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Habiger David C bought 2,100 shares at $47.59 (≈$99.94K) on Aug 5, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 6, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Habiger David C bought 140 shares at $48.59 (≈$6.80K) on Aug 4, 2026
- Habiger David C bought 1,042 shares at $48.07 (≈$50.09K) on Aug 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 3, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $5.44B (prior year $5.06B) (+7.5% vs Jun 30, 2025)
- Diluted EPS: $0.61 (prior year $0.53) (+15.1% vs Jun 30, 2025)
Jul 29, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 27, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.05 — Costs tied to exiting activities / restructuring.
Jun 24, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade BSX
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 22, 2026, Feb 4, 2026, Oct 22, 2025. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.14% (largest 2.7%).
- Liquidity: about 17.70M shares (≈$781.12M) trade per day on average.
- 52-week position: $44.14 vs a range of $41.39–$105.65 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 10 open-market buys, 11 sales; latest: Susan E Morano bought 2,040 shares on Aug 25, 2026.
- Latest filings: 8-K Oct 7, 2026; 8-K Sep 23, 2026; 8-K Sep 8, 2026.
- Share count: 1.45B shares outstanding (Jul 30, 2026), -2.2% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
BSX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 43.95 | 44.43 | 43.46 | 44.14 | 15.86M |
| Oct 14, 2026 | 43.40 | 43.58 | 42.28 | 43.00 | 15.10M |
| Oct 13, 2026 | 43.95 | 44.15 | 42.46 | 43.31 | 14.27M |
| Oct 12, 2026 | 43.10 | 43.92 | 42.67 | 43.84 | 13.60M |
| Oct 9, 2026 | 42.12 | 42.83 | 41.97 | 42.73 | 13.04M |
| Oct 8, 2026 | 41.50 | 42.27 | 41.39 | 42.04 | 22.87M |
| Oct 7, 2026 | 42.19 | 42.52 | 41.50 | 41.58 | 15.89M |
| Oct 6, 2026 | 42.47 | 42.75 | 42.00 | 42.19 | 12.55M |
| Oct 5, 2026 | 42.53 | 43.30 | 42.29 | 42.40 | 13.74M |
| Oct 2, 2026 | 43.32 | 43.44 | 41.94 | 42.60 | 18.31M |
| Oct 1, 2026 | 43.51 | 43.96 | 42.95 | 43.23 | 17.93M |
| Sep 30, 2026 | 43.74 | 43.97 | 43.30 | 43.65 | 17.97M |
| Sep 29, 2026 | 44.15 | 44.30 | 43.22 | 43.88 | 14.60M |
| Sep 28, 2026 | 43.91 | 44.15 | 43.17 | 44.11 | 21.78M |
| Sep 25, 2026 | 44.68 | 44.84 | 43.33 | 43.92 | 15.21M |
| Sep 24, 2026 | 44.65 | 45.16 | 44.46 | 44.68 | 17.30M |
| Sep 23, 2026 | 45.00 | 45.74 | 43.99 | 44.62 | 18.56M |
| Sep 22, 2026 | 44.70 | 45.08 | 44.04 | 44.92 | 21.07M |
| Sep 21, 2026 | 42.98 | 43.81 | 42.72 | 43.72 | 25.00M |
| Sep 18, 2026 | 43.08 | 43.90 | 43.05 | 43.34 | 29.28M |
About Boston Scientific
Boston Scientific (BSX) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in MARLBOROUGH, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 885725.
BSX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David C Habiger | Director | Aug 7, 2026 |
| Edward J Ludwig | Director | Aug 3, 2026 |
| Michael F Mahoney | Chairman, President & CEO | Aug 5, 2026 |
| Jessica L Mega | Director | May 11, 2026 |
| Susan E Morano | Director | Aug 26, 2026 |
| Cheryl Pegus | Director | May 21, 2026 |
| Cathy R Smith | Director | May 11, 2026 |
| David S Wichmann | Director | May 11, 2026 |
| Christophe Pierre Weber | Director | May 11, 2026 |
| Ellen M Zane | Director | May 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Vance R Brown | EVP, GC and Corp. Secretary | Feb 18, 2026 |
| Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | May 4, 2026 |
| Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | Aug 3, 2026 |
| Michael F Mahoney | Chairman, President & CEO | Aug 5, 2026 |
| Jonathan Monson | EVP and CFO | Aug 11, 2026 |
| Padraig Andrew O'Connor | EVP, Global Operations | Sep 3, 2026 |
| Miriam O'Sullivan | SVP, Chief HR Officer | Feb 18, 2026 |
| Emily Woodworth | SVP, Global Controller and CAO | Aug 12, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Susan E Morano | Buy | 2,040 | $49.22 |
| Aug 5, 2026 | David C Habiger | Buy | 2,100 | $47.59 |
| Aug 4, 2026 | David C Habiger | Buy | 140 | $48.59 |
| Aug 3, 2026 | David C Habiger | Buy | 1,042 | $48.07 |
| Aug 3, 2026 | Michael F Mahoney | Buy | 186,240 | $48.33 |
| Jul 31, 2026 | Edward J Ludwig | Buy | 5,000 | $45.48 |
| May 20, 2026 | Edward J Ludwig | Buy | 3,580 | $56.68 |
| May 20, 2026 | David C Habiger | Buy | 2,250 | $55.92 |
| May 20, 2026 | Cheryl Pegus | Buy | 1,770 | $56.49 |
| May 19, 2026 | David C Habiger | Buy | 2,200 | $56.95 |
| Feb 2, 2026 | Michael F Mahoney | Sale | 159,701 | $93.49 |
| Feb 2, 2026 | Michael F Mahoney | Sale | 1,200 | $94.06 |
| Dec 1, 2025 | Arthur C Butcher | Sale | 17,313 | $101.55 |
| Nov 6, 2025 | Ellen M Zane | Sale | 12,891 | $98.28 |
| Nov 3, 2025 | Joseph Michael Fitzgerald | Sale | 16,928 | $99.76 |
BSX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $20.07B | — | 1.94 | $4.53B |
| Dec 31, 2024 | $16.75B | — | 1.25 | $3.44B |
| Dec 31, 2023 | $14.24B | — | 1.07 | $2.50B |
| Dec 31, 2022 | $12.68B | — | 0.45 | $1.53B |
| Dec 31, 2021 | $11.89B | — | 0.69 | $1.87B |
Latest balance sheet: total assets $45.22B, total liabilities $—, cash $539.00M (as of Jun 30, 2026).
BSX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $46.04 |
| Apr 22, 2026 | 8-K Item 2.02 (results) | $64.87 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $75.50 |
| Oct 22, 2025 | 8-K Item 2.02 (results) | $103.85 |
| Jul 23, 2025 | 8-K Item 2.02 (results) | $107.76 |
| Apr 23, 2025 | 8-K Item 2.02 (results) | $98.92 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $104.97 |
| Oct 23, 2024 | 8-K Item 2.02 (results) | $87.45 |
| Jul 24, 2024 | 8-K Item 2.02 (results) | — |
| Apr 24, 2024 | 8-K Item 2.02 (results) | — |
| Jan 31, 2024 | 8-K Item 2.02 (results) | — |
| Oct 26, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)Globus Medical (GMED)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on BSX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.